Track topics on Twitter Track topics that are important to you
PDL Biopharma, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.
Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
An indepth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends
Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects
PDL Biopharma PDL or 'the company' is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada. It employed 10 people as of December 31, 2014.
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...